BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25547434)

  • 1. AURKA is a predictor of chemotherapy response and prognosis for patients with advanced oral squamous cell carcinoma.
    Li Y; Zhang J
    Tumour Biol; 2015 May; 36(5):3557-64. PubMed ID: 25547434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
    Wen J; Xu H; Liu R; Chen Q; Dai Y; Xu Y
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):24-31. PubMed ID: 32538743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Aurora kinase A suppresses the growth of human oral squamous cell carcinoma cells in vitro and in vivo.
    Tanaka H; Nakashiro K; Iwamoto K; Tokuzen N; Fujita Y; Shirakawa R; Oka R; Goda H; Hamakawa H
    Oral Oncol; 2013 Jun; 49(6):551-9. PubMed ID: 23481312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
    Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
    Dawei H; Honggang D; Qian W
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
    Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
    Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma.
    Luo SD; Chen YJ; Liu CT; Rau KM; Chen YC; Tsai HT; Chen CH; Chiu TJ
    Biomed Res Int; 2015; 2015():508587. PubMed ID: 26491674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora-A affects radiosenstivity in cervical squamous cell carcinoma and predicts poor prognosis.
    Ma Y; Yang J; Wang R; Zhang Z; Qi X; Liu C; Ma M
    Oncotarget; 2017 May; 8(19):31509-31520. PubMed ID: 28404933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stathmin guides personalized therapy in oral squamous cell carcinoma.
    Ju WT; Ma HL; Zhao TC; Liang SY; Zhu DW; Wang LZ; Li J; Zhang ZY; Zhou G; Zhong LP
    Cancer Sci; 2020 Apr; 111(4):1303-1313. PubMed ID: 31994271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).
    Auzair LB; Vincent-Chong VK; Ghani WM; Kallarakkal TG; Ramanathan A; Lee CE; Rahman ZA; Ismail SM; Abraham MT; Zain RB
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1885-93. PubMed ID: 26138391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease.
    Zhong LP; Zhu DW; William WN; Liu Y; Ma J; Yang CZ; Yang X; Wang LZ; Li J; Myers JN; Lee JJ; Zhang CP; Zhang ZY
    Mol Cancer Ther; 2013 Jun; 12(6):1112-21. PubMed ID: 23515614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate dehydrogenase B is associated with the response to neoadjuvant chemotherapy in oral squamous cell carcinoma.
    Sun W; Zhang X; Ding X; Li H; Geng M; Xie Z; Wu H; Huang M
    PLoS One; 2015; 10(5):e0125976. PubMed ID: 25973606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
    Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
    BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan.
    Chou CH; Chou YE; Chuang CY; Yang SF; Lin CW
    PLoS One; 2017; 12(2):e0171583. PubMed ID: 28152093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
    Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
    Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma.
    Yang JS; Lin CW; Chuang CY; Su SC; Lin SH; Yang SF
    Tumour Biol; 2015 Dec; 36(12):9517-24. PubMed ID: 26130414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
    Mohanta S; Sekhar Khora S; Suresh A
    Arch Oral Biol; 2019 Mar; 99():92-106. PubMed ID: 30641296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
    Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of stathmin 1 is a strong prognostic marker in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.
    Harada K; Ferdous T; Harada T; Ueyama Y
    Clin Exp Med; 2017 Feb; 17(1):45-50. PubMed ID: 26590596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.